How does Sitagliptin enhance insulin secretion in advanced diabetes, particularly in patients with significant beta-cell dysfunction?
Share
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Sitagliptin inhibits the enzyme DPP-4, increasing GLP-1 levels, which enhances insulin secretion and decreases glucagon release, improving glycemic control even with beta-cell dysfunction.